GP9 p.Phe71Ser
c.212T>C · rs121918037 · VCV13531
ClinGen expert panel — Platelet Disorders VCEP
Pathogenic for Bernard-Soulier syndrome. Applied ACMG criteria (verbatim):
PM2_Supporting PP1_Moderate PS3_Supporting PM5_Supporting PM3_Strong PP4
Curation rationale (ClinGen, verbatim)
The c.212C>T variant in GP9 is a missense variant predicted to cause substitution of phenylalanine by serine at amino acid 71. This variant has been detected in at least 16 probands with Bernard-Soulier syndrome. This variant has been detected in at least 8 probands with supporting laboratory results described in the literature (PM3_Strong). Two of these probands were compound heterozygous for this variant and another variant (c.266G>A [p.Cys89Tyr], c.182A>G [p.Asn61Ser]) (PMID:24934643). Six of these probands were homozygous for the variant, with at least 3 of these confirmed using parental testing or other methods (PMIDs: 9163595, 432024, 21173099, 21699652, 25539746). At least one patient (proband in PMID: 9432024) with this variant had aggregation absent for ristocetin and present for all other agonists and flow cytometry with less than 10% expression of GPIba, which is highly specific for Bernard-Soulier syndrome (PP4). The variant has been reported to segregate with Bernard-Soulier syndrome in the proband plus two affected family members, all with the homozygous genotype (PP1_moderate; PMID:17763149). Another missense variant in the same codon has been reported in a patient with Bernard-Soulier syndrome c.212T>G, p.Phe71Cys (PMID:21699652), classified likely pathogenic by the ClinGen PD VCEP (PM5_supporting). The highest minor allele frequency in gnomaDv4.1 is 0.00003294 (3/91084 alleles) in the South Asian genetic ancestry group, which is below the <0.0000329 threshold for PM2_supporting. Surface expression of GP1Ba measured by flow cytometry in CHO-K1 cells transiently co-transfected with the c.212T>C variant in GP9 and wild type GP1Bb showed decreased expression at ~17% (<25%) WT levels, indicating that this variant impacts protein function (PMID:10527407; PS3_Supporting). In summary, this variant meets the criteria to be classified as pathogenic for autosomal recessive Bernard-Soulier syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PP4, PM3_strong, PM2_Supporting, PS3_Supporting, PP1_Moderate, PM5_supporting (VCEP specifications version 1).
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9716 | likely pathogenic ✓ concordant with ClinVar · top 1% in GP9 |
|---|---|---|
| REVEL | 0.634 | indeterminate |
| SaProt | LLR -13.74 | damaging |
| ⇒ AlphaMissense and SaProt both call this damaging; REVEL is indeterminate. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.5 | GERP 1.5, phastCons 1 |
| Regional constraint | o/e 0.94 | unconstrained · MANE · 530 bp · p 0.38 · regional, not allelic |
| Overall | ||
| CADD | 24.4 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.00329% | 30,361 |
| East Asian | 0.00223% | 44,894 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,478 |
| African / African-American | 0.00133% | 74,932 |
| European (non-Finnish) | 0.00102% | 98,325 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- GP9
- Protein
- p.Phe71Ser
- Coding
- c.212T>C
- MANE Select
- NM_000174
- dbSNP
- rs121918037
- Type
- single nucleotide variant
- Location
- chr3:129061951 (GRCh38)
- Structure
- AlphaFold pLDDT 84.43 · 2 PDB
- Residue 71
- a UniProt-annotated variant site (in bss); a turn
Disease context
Bernard-Soulier syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Bernard-Soulier syndrome (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive
- Onset
- All ages
Similar variants
- GP9 p.Phe71Cys Likely pathogenic ★★★ same residue
- GP9 p.Asn61Ser Pathogenic ★★★ same condition
- GP9 p.Cys135Tyr Likely pathogenic ★★★ ⚠ same condition
- GP9 p.Cys24Arg Likely pathogenic ★★★ same condition
- GP9 p.Cys38Arg Likely pathogenic ★★★ same condition
- GP9 p.Cys89Tyr Pathogenic ★★★ same condition
- GP9 p.Leu56Pro Likely pathogenic ★★★ same condition
- GP9 p.Leu7Pro Likely pathogenic ★★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gp9-p-phe71ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown